Drug Discovery Technology Europe 2001
Drug Discovery Technology 2001
Messe Stuttgart International
April 23-26, 2001
See MDL's comprehensive discovery informatics solutions in action at Drug Discovery Technology Europe 2001! Stop by our booth to see what we have in store for you!
This congress is now the premier focus in Europe for scientists and managers interested in all aspects of drug discovery. Participants span the range from fledgling biotechs to major pharma, and our blend of formal and informal sessions is intended to stimulate synergistic interactions throughout the conference.
Although the sequencing of the human genome was an outstanding landmark, there are still tremendous challenges in transforming the genomics revolution into tangible products. Indeed, our conference theme of ‘where science meets business’ is a timely reminder of the significant productivity issues facing the pharmaceutical industry. Therefore, major themes that run throughout this meeting will address the impact of genome science and new technologies on such key topics as target selection, lead identification and candidate survival. Future organisation paradigms will also be discussed, with significant emphasis on partnering.
With over 55 top level speakers, 80 exhibitors and more than 850 participants, Drug Discovery Technology 2001 provides an unparalleled opportunity to hear and discuss the major strategic, technology and partnering challenges that face the biopharmaceutical industry over the next decade.
Please send comments or questions about this site to firstname.lastname@example.org.